145 related articles for article (PubMed ID: 8856161)
1. Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system.
Bartus RT; Elliott P; Hayward N; Dean R; McEwen EL; Fisher SK
Immunopharmacology; 1996 Jun; 33(1-3):270-8. PubMed ID: 8856161
[TBL] [Abstract][Full Text] [Related]
2. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation.
Emerich DF; Dean RL; Osborn C; Bartus RT
Clin Pharmacokinet; 2001; 40(2):105-23. PubMed ID: 11286321
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7.
Elliott PJ; Hayward NJ; Dean RL; Bartus RT
Immunopharmacology; 1996 Jun; 33(1-3):205-8. PubMed ID: 8856151
[No Abstract] [Full Text] [Related]
4. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.
Bartus RT; Elliott PJ; Dean RL; Hayward NJ; Nagle TL; Huff MR; Snodgrass PA; Blunt DG
Exp Neurol; 1996 Nov; 142(1):14-28. PubMed ID: 8912895
[TBL] [Abstract][Full Text] [Related]
5. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.
Elliott PJ; Hayward NJ; Huff MR; Nagle TL; Black KL; Bartus RT
Exp Neurol; 1996 Oct; 141(2):214-24. PubMed ID: 8812155
[TBL] [Abstract][Full Text] [Related]
6. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase.
Uchida M; Chen Z; Liu Y; Black KL
Neurol Res; 2002 Dec; 24(8):739-46. PubMed ID: 12500695
[TBL] [Abstract][Full Text] [Related]
8. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
Dean RL; Emerich DF; Hasler BP; Bartus RT
Neuro Oncol; 1999 Oct; 1(4):268-74. PubMed ID: 11550318
[TBL] [Abstract][Full Text] [Related]
9. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
[TBL] [Abstract][Full Text] [Related]
10. Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors.
Liu Y; Hashizume K; Chen Z; Samoto K; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Jun; 23(4):379-87. PubMed ID: 11428519
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity.
Borlongan CV; Emerich DF; Hoffer BJ; Bartus RT
Brain Res; 2002 Nov; 956(2):211-20. PubMed ID: 12445688
[TBL] [Abstract][Full Text] [Related]
12. The bradykinin analog RMP-7 increases intracellular free calcium levels in rat brain microvascular endothelial cells.
Doctrow SR; Abelleira SM; Curry LA; Heller-Harrison R; Kozarich JW; Malfroy B; McCarroll LA; Morgan KG; Morrow AR; Musso GF
J Pharmacol Exp Ther; 1994 Oct; 271(1):229-37. PubMed ID: 7965719
[TBL] [Abstract][Full Text] [Related]
13. Role of activation of bradykinin B2 receptors in disruption of the blood-brain barrier during acute hypertension.
Mayhan WG
Brain Res; 1996 Nov; 738(2):337-41. PubMed ID: 8955532
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier.
Easton AS; Abbott NJ
Brain Res; 2002 Oct; 953(1-2):157-69. PubMed ID: 12384249
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
Field JL; Butt SK; Morton IK; Hall JM
Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
[TBL] [Abstract][Full Text] [Related]
16. Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport.
Borlongan CV; Emerich DF
Brain Res Bull; 2003 May; 60(3):297-306. PubMed ID: 12754091
[TBL] [Abstract][Full Text] [Related]
17. B2 receptor-mediated enhanced bradykinin sensitivity of rat cutaneous C-fiber nociceptors during persistent inflammation.
Banik RK; Kozaki Y; Sato J; Gera L; Mizumura K
J Neurophysiol; 2001 Dec; 86(6):2727-35. PubMed ID: 11731532
[TBL] [Abstract][Full Text] [Related]
18. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas.
Matsukado K; Sugita M; Black KL
Brain Res; 1998 May; 792(1):10-5. PubMed ID: 9593802
[TBL] [Abstract][Full Text] [Related]
19. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
20. Cereport (RMP-7) increases the permeability of human brain microvascular endothelial cell monolayers.
Mackic JB; Stins M; Jovanovic S; Kim KS; Bartus RT; Zlokovic BV
Pharm Res; 1999 Sep; 16(9):1360-5. PubMed ID: 10496650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
